Sunshine Biopharma Inc. - 8-K Filing
Sunshine Biopharma reduced the exercise price of its Series B Warrants to $1.2046 due to recent common stock sales under an at-the-market offering. (Items: 8.01 Other Events)
Tickers: $SBFM
Sunshine Biopharma reduced the exercise price of its Series B Warrants to $1.2046 due to recent common stock sales under an at-the-market offering. (Items: 8.01 Other Events)
Tickers: $SBFM